The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
Chagas disease and leishmaniasis are both neglected tropical diseases that affect millions of people around the world. Leishmaniasis is currently the second most widespread vector-borne parasitic disease after malaria. The World Health Organization records approximately 0.7–1 million newly diagnosed...
Main Authors: | Hayelom Berhe, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun, Nir Qvit |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/2/227 |
Similar Items
-
Chagas Disease and Breast-feeding
by: Francesca F. Norman, et al.
Published: (2013-10-01) -
Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
by: Eliana B. Souto, et al.
Published: (2019-08-01) -
COVID-19: Implications for People with Chagas Disease
by: Ezequiel José Zaidel, et al.
Published: (2020-10-01) -
Severe Chagas disease in Ecuador: a countrywide geodemographic epidemiological analysis from 2011 to 2021
by: Jorge Vásconez-González, et al.
Published: (2023-04-01) -
Editorial: Computational approaches to build therapeutic paradigms targeting genes, proteins and pathways against neglected tropical diseases (NTDs)
by: Anupam Nath Jha
Published: (2023-05-01)